We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AGN:EURONEXT AMSTERDAMAegon Ltd. Analysis

Data as of 2026-07-09 - not real-time

$11.07

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

AGNC Investment Corp. trades at a **trailing P/E of 8.6**, far below the industry average of 31.8, and its price‑to‑book sits at 1.24, suggesting the stock may be **undervalued** relative to peers. The company offers an eye‑catching **13.2% dividend yield**, but the payout ratio exceeds 100% (112.5%), raising questions about **sustainability** given its modest earnings per share and zero free cash flow. Balance‑sheet metrics reveal extreme leverage, with a debt‑to‑equity ratio above 700, and cash balances that cover only a fraction of total debt, highlighting **financial risk**. Recent news confirms the continuation of the monthly cash dividend, reinforcing the high yield but not addressing the underlying payout strain.
Technical indicators show a **bullish MACD crossover** and an RSI of 61.7, indicating modest upside momentum, while the stock sits just below the **$11.25 resistance** and above the **$10.17 support** level. Volume is increasing, which supports the bullish signal, yet the broader **volatility of 20%** and a **beta below 1** suggest moderate price swings. Considering the blend of attractive valuation, high but potentially fragile dividend, and elevated leverage, the recommendation is to **hold** the position while monitoring interest‑rate trends and dividend policy adjustments.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD and supportive volume
  • Proximity to resistance at $11.25
  • High dividend yield with unsustainable payout

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant leverage (debt‑to‑equity > 700)
  • Valuation advantage (low P/E vs industry)
  • Potential interest‑rate impact on mortgage REIT earnings

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Continued dividend pressure if earnings do not improve
  • Regulatory environment for GSE‑backed securities
  • Long‑term balance‑sheet restructuring needs

Key Metrics & Analysis

Financial Health

Profit Margin91.71%
P/E Ratio8.6
ROE13.25%
ROA1.37%
Debt/Equity722.90
P/B Ratio1.2
Op. Cash Flow$848.0M
Industry P/E31.8

Technical Analysis

TrendNeutral
RSI61.7
Support$10.17
Resistance$11.25
MA 20$10.67
MA 50$10.57
MA 200$10.60
MACDBullish
VolumeIncreasing
Fear & Greed Index93.14

Valuation

Target Price$11.44
Upside/Downside3.32%
GradeUndervalued
TypeValue
Dividend Yield13.16%

Risk Assessment

Beta0.70
Volatility20.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.